Zevra Therapeutics, Inc. (ZVRA)
11.65
-0.22
(-1.85%)
USD |
NASDAQ |
Aug 24, 16:00
11.66
+0.01
(+0.09%)
After-Hours: 20:00
Zevra Therapeutics Price : 11.65 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 11.98 | 12.01 | 11.45 | 11.65 | 784475.0 |
| Aug 21, 2026 | 11.96 | 12.01 | 11.75 | 11.87 | 704113.0 |
| Aug 20, 2026 | 12.04 | 12.18 | 11.86 | 11.89 | 924664.0 |
| Aug 19, 2026 | 11.78 | 12.15 | 11.65 | 12.13 | 1.118M |
| Aug 18, 2026 | 11.48 | 11.64 | 11.32 | 11.57 | 911556.0 |
| Aug 17, 2026 | 11.27 | 11.58 | 11.18 | 11.53 | 754271.0 |
| Aug 14, 2026 | 11.01 | 11.36 | 10.81 | 11.32 | 777779.0 |
| Aug 13, 2026 | 11.47 | 11.60 | 11.14 | 11.18 | 807987.0 |
| Aug 12, 2026 | 11.46 | 11.50 | 11.35 | 11.44 | 708532.0 |
| Aug 11, 2026 | 11.52 | 11.57 | 11.32 | 11.34 | 710556.0 |
| Aug 10, 2026 | 11.47 | 11.53 | 11.22 | 11.48 | 794201.0 |
| Aug 07, 2026 | 11.91 | 11.97 | 11.35 | 11.56 | 1.263M |
| Aug 06, 2026 | 11.30 | 12.32 | 11.08 | 11.88 | 2.494M |
| Aug 05, 2026 | 10.59 | 10.66 | 10.37 | 10.53 | 781393.0 |
| Aug 04, 2026 | 10.23 | 10.53 | 10.10 | 10.52 | 1.285M |
| Aug 03, 2026 | 9.51 | 10.08 | 9.49 | 10.06 | 1.754M |
| Jul 31, 2026 | 9.70 | 9.753 | 9.34 | 9.51 | 971430.0 |
| Jul 30, 2026 | 9.79 | 9.87 | 9.495 | 9.64 | 1.917M |
| Jul 29, 2026 | 9.72 | 9.845 | 9.44 | 9.78 | 1.043M |
| Jul 28, 2026 | 9.81 | 9.81 | 9.39 | 9.73 | 1.505M |
| Jul 27, 2026 | 9.53 | 9.99 | 9.470 | 9.71 | 1.713M |
| Jul 24, 2026 | 9.205 | 10.19 | 9.10 | 9.525 | 6.941M |
| Jul 23, 2026 | 12.00 | 12.56 | 11.81 | 12.52 | 965777.0 |
| Jul 22, 2026 | 12.42 | 12.50 | 11.91 | 12.14 | 941396.0 |
| Jul 21, 2026 | 12.07 | 12.53 | 12.02 | 12.45 | 867049.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Innoviva, Inc. | 21.03 |
| Collegium Pharmaceutical, Inc. | 27.35 |
| Johnson & Johnson | 273.04 |
| Ligand Pharmaceuticals, Inc. | 280.18 |
| Harrow, Inc. | 39.80 |
Price Related Metrics
| PE Ratio | 12.57 |
| PS Ratio | 5.086 |
| Price to Book Value | 3.176 |
| Price to Free Cash Flow | 21.21 |
| Earnings Yield | 7.96% |
| Market Cap | 691.33M |
| Operating PE Ratio | 17.71 |
| Normalized PE Ratio | 10.27 |